David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZPN
2176
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.05M | ﹤0.01% |
44,979
-143,386
| -76% | -$6.53M |
|
2177
PUT
JD.com
JD
$38.9B
| $2.05M | ﹤0.01% |
+60,000
| New | +$2.04M |
|
2178
Insight Enterprises
NSIT
$4.46B
| $2.04M | ﹤0.01% |
68,371
+27,773
| +68% | +$825K |
|
2179
Hancock Whitney
HWC
$6.04B
| $2.04M | ﹤0.01% |
64,002
+26,839
| +72% | +$814K |
|
|
CASC
2180
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.04M | ﹤0.01% |
90,848
-105,676
| -54% | -$1.67M |
|
|
SUNE
2181
CALL
DELISTED
SUNEDISON, INC COM
SUNE
| $2.03M | ﹤0.01% |
68,000
| – | – |
|
2182
CALL
Stratasys
SSYS
$694M
| $2.03M | ﹤0.01% |
58,100
+24,300
| +72% | +$1.02M |
|
2183
CALL
Churchill Downs
CHDN
$6.1B
| $2.03M | ﹤0.01% |
97,200
+60,000
| +161% | +$1.21M |
|
|
PMCS
2184
DELISTED
P M C SIERRA INC
PMCS
| $2.02M | ﹤0.01% |
236,218
+72,469
| +44% | +$647K |
|
2185
Adtran
ADTN
$645M
| $2.02M | ﹤0.01% |
124,048
+42,790
| +53% | +$734K |
|
2186
Supernus Pharmaceuticals
SUPN
$2.61B
| $2.01M | ﹤0.01% |
118,428
+108,119
| +1,049% | +$1.54M |
|
2187
KB Home
KBH
$3.44B
| $2.01M | ﹤0.01% |
+121,015
| New | +$1.85M |
|
2188
Palo Alto Networks
PANW
$277B
| $2.01M | ﹤0.01% |
69,006
+53,406
| +342% | +$1.43M |
|
2189
Mistras Group
MG
$599M
| $2.01M | ﹤0.01% |
105,800
+18,075
| +21% | +$337K |
|
|
RAD
2190
PUT
DELISTED
Rite Aid Corporation
RAD
| $2.01M | ﹤0.01% |
12,010
+4,000
| +50% | +$671K |
|
|
NATI
2191
DELISTED
National Instruments Corp
NATI
| $2M | ﹤0.01% |
67,971
-77,733
| -53% | -$2.39M |
|
2192
Gibraltar Industries
ROCK
$1.38B
| $2M | ﹤0.01% |
98,214
+27,939
| +40% | +$507K |
|
2193
Sixth Street Specialty
TSLX
$1.79B
| $2M | ﹤0.01% |
117,664
+37,854
| +47% | +$681K |
|
|
DOC
2194
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2M | ﹤0.01% |
129,990
+104,731
| +415% | +$1.74M |
|
2195
CALL
General Mills
GIS
$21.4B
| $1.99M | ﹤0.01% |
35,700
| – | – |
|
|
TW
2196
PUT
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $1.99M | ﹤0.01% |
+15,800
| New | +$2.12M |
|
|
SREV
2197
DELISTED
ServiceSource International, Inc.
SREV
| $1.99M | ﹤0.01% |
362,810
+73,781
| +26% | +$307K |
|
2198
MiMedx Group
MDXG
$644M
| $1.98M | ﹤0.01% |
171,076
-389,318
| -69% | -$4.01M |
|
2199
CALL
Roper Technologies
ROP
$40.9B
| $1.98M | ﹤0.01% |
+11,500
| New | +$1.99M |
|
|
GAU
2200
Galiano Gold
GAU
$620M
| $1.98M | ﹤0.01% |
1,124,238
-193,300
| -15% | -$312K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.